Intec pharma ltd. (NTEC)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS

-47,599

-43,543

-28,909

-

-

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation

854

859

829

-

-

IMPAIRMENT OF LONG-LIVED ASSETS

13,663

-

-

-

-

Comprehensive loss

-

-

-

-13,362

-7,180

Adjustments to reconcile loss and comprehensive loss to net cash used in operating activities (see appendix A)

-

-

-

1,357

-751

Net cash used in operating activities

-

-

-

-12,005

-7,931

Purchase of property and equipment

-

-

-

482

1,384

Advances payments for property and equipment

-

-

-

0

0

Short-term deposits, net

-

-

-

5,000

-5,000

Proceeds from disposal of financial assets at fair value through profit or loss, net

-

-

-

206

0

Changes in restricted bank deposits, net

-

-

-

0

13

Proceeds from sale of property and equipment

-

-

-

0

0

Net cash used in investing activities

-

-

-

4,724

-6,371

Issuance of shares, net of issuance costs

-

-

-

0

30,608

Exercise of warrants (series 7)

-

-

-

0

1,844

Exercise of warrants

-

-

-

0

0

Exercise of options by employees

-

-

-

0

0

Net cash provided by financing activities

-

-

-

0

32,452

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-

-7,281

18,150

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-

-

-

8

-232

Depreciation

-

-

-

701

746

Changes in the fair value of derivative financial instruments

-

-

-

230

-213

Exchange differences on cash and cash equivalents

67

829

-127

8

403

Change in right of use asset

967

-

-

-

-

Change in lease liabilities

713

-

-

-

-

Gains on marketable securities

13

-194

220

-

-

Loss from sale of property and equipment

-

-

-2

-

-

Share-based compensation

3,221

3,227

1,203

-

-

Changes in operating assets and liabilities:
Increase in prepaid expenses and other receivables

747

1,861

-

-

-

Increase in prepaid expenses and other receivables

-

-

-1,259

-

-

Increase in deferred tax assets

-281

281

-

-

-

Increase (decrease) in accounts payable and accruals

679

1,191

3,831

-

-

Increase in other liabilities

295

309

-

-

-

Net cash used in operating activities

-29,045

-39,076

-22,132

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

921

4,667

5,001

-

-

Investment in other assets

2,865

4,932

-

-

-

Proceeds from disposal of marketable securities, net

576

298

247

-

-

Proceeds from sale of property and equipment

-

-

7

-

-

Net cash (used in) provided by investing activities

-3,210

-9,301

-4,747

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of ordinary shares, net of issuance costs

2,086

35,029

63,131

-

-

Proceeds from exercise of warrants

-

-

531

-

-

Proceeds from exercise of options

282

30

45

-

-

Net cash provided by financing activities

2,368

35,059

63,707

-

-

DECREASE IN CASH AND CASH EQUIVALENTS

-29,887

-13,318

-

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

36,828

-

-

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-67

-829

127

-

-

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Liability with respect to property and equipment

-

170

-

-

-

Liability with respect to other assets (see note 4a)

-

499

-

-

-

SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION -
Taxes paid

75

96

-

-

-

Interest received

327

734

244

-

-

Exchange differences on restricted deposits

-

-

-

0

0

Exchange differences on short-term bank deposit

-

-

-

0

0

Losses (gains) on financial assets at fair value through profit or loss

-

-

-

34

19

Loss on sale of property and equipment

-

-

-

0

0

Share-based compensation

-

-

-

536

381

Income and expenses not involving cash flows

-

-

-

965

918

Decrease (increase) in other receivables

-

-

-

-23

-2,083

Increase in accounts payable and accruals

-

-

-

415

414

Changes in operating asset and liability

-

-

-

392

-1,669

Adjustments to reconcile net loss to net cash provided from operations

-

-

-

1,357

-751

Liability with respect to property purchase

-

-

-

190

0

Settlement of liability in respect to derivative financial instrument to equity

-

-

-

0

1,060

Interest received

-

-

-

168

44